Global Prosthetic Heart Valves Market: Drivers, Restraints, Opportunities, and Challenge

Published: Mon Sep 24 2018

The prosthetic heart valve market is projected to reach USD 8.86 Billion by 2022 from USD 4.84 Billion in 2017, at a CAGR of 12.9%. Market growth can be attributed to the rising geriatric population and the subsequent increase in the prevalence of HVD, regulatory approvals for new and advanced prosthetic heart valves, increasing government funding for heart valve research, rising awareness about HVD, and favorable reimbursement scenario for prosthetic heart valves.

Years considered for this report
2016 – Base Year
2017 – Estimated Year
2022 – Projected Year

The objectives for this study are as follows:
To define, describe, and forecast the prosthetic heart valve market on the basis of type of valve and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
To profile the key players and comprehensively analyze their market shares and core competencies in terms of market development and growth strategies
To track and analyze competitive developments such as marketing and promotional activities, approvals, product launches, acquisitions, agreements, collaborations, expansions, certifications, and reimbursement approvals in the prosthetic heart valves market

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

This research report categorizes the global prosthetic heart valve market into the following segments:

Prosthetic Heart Valve Market, by Type of Valve
Transcatheter Heart Valves
Tissue Heart Valves
Mechanical Heart Valves

Prosthetic Heart Valve Market, by Region
North America
Rest of Europe (RoE)
Rest of Asia-Pacific (RoAPAC)
Rest of the World (RoW)

The key players in the artificial heart valve market are Medtronic plc (Ireland), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomédica (Brazil).

Target Audience for this Report:
Prosthetic Heart Valve Manufacturing Companies
Suppliers and Distributors of Prosthetic Heart Valves
Healthcare Service Providers
Teaching Hospitals and Academic Medical Centers (AMCs)
Health Insurance Players
Research and Consulting Firms
Medical Research Institutes
Audiology Centers
Healthcare Institutions/Providers (Hospitals, Medical Institutes, and Governing Bodies)
Venture Capitalists
Community Centers
Regulatory Authorities

To Know More @
Contact Name: 1marketsandmarkets
Contact Email:

Visit website »